The Novel Prognostic Index Model of Combining Circulating Tumor DNA and PINK-E Predicts the Clinical Outcomes for Newly Diagnosed Extranodal NK/T-cell Lymphoma-Reference-Cited by-同舟云学术

The Novel Prognostic Index Model of Combining Circulating Tumor DNA and PINK-E Predicts the Clinical Outcomes for Newly Diagnosed Extranodal NK/T-cell Lymphoma

Published:2022-12-20 Issue:1 Volume:7 Page:e822
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Huang Dezhi,Li Qiong,Li Xinlei,Ma Naya,Duan Yishuo,Zhu Lidan,Li Jiali,Wen Qin,Gao Lei,Yang Cheng,Rao Lingyi,Gao Li,Zhang Xi,Rao Jun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference53 articles.

1. How I treat NK/T-cell lymphomas.;Tse;Blood,2013

2. What we should know about natural killer/T-cell lymphomas.;Xiong;Hematol Oncol,2019

3. Mortality of lymphoma and myeloma in China, 2004-2017: an observational study.;Liu;J Hematol Oncol,2019

4. Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review.;Kim;J Hematol Oncol,2018

5. Prognostic nomogram for overall survival in early stage extranodal natural killer/T cell lymphoma treated with high-dose radiotherapy.;Huang;Clin Lymphoma Myeloma Leuk,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future;Blood Reviews;2024-09

2. Minimal residual disease detection in lymphoma: methods, procedures and clinical significance;Frontiers in Immunology;2024-08-12

3. Circulating tumor DNA in NK/T and peripheral T cell lymphoma;Seminars in Hematology;2023-07

4. How molecular advances may improve the diagnosis and management of PTCL patients;Frontiers in Oncology;2023-06-23